Mechanical Thrombectomy With or Without Extracranial Proximal Carotid Artery Stenting for Acute Ischemic Stroke Due to Tandem or Local Occlusion
Led by Mercy Health Ohio · Updated on 2026-10-02
404
Participants Needed
60
Research Sites
39 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness of intra-arterial mechanical thrombectomy combined with either extracranial proximal carotid artery acute stenting or non-stenting approaches in adults who have an acute ischemic stroke caused by blockage in blood vessels of the brains anterior circulation along with severe narrowing or blockage in the proximal carotid artery. This phase III, randomized, open-label trial aims to determine whether stenting improves outcomes compared to non-stenting treatments in this patient group.
Participants will be randomly assigned to one of two groups. One group will receive best medical management plus mechanical thrombectomy and treatment of the proximal carotid artery without stenting, using angioplasty or aspiration. The other group will receive the same medical and mechanical thrombectomy treatment but with acute carotid stenting of the extracranial carotid artery. Both procedures will use FDA-approved devices following instructions for use. The order of treating the intracranial and extracranial lesions is decided by the treating doctor. Within the stenting group, there are subgroups based on different antiplatelet medication protocols, either oral or intravenous.
Participants will be followed and assessed at 3 months and 1 year after randomization to measure their neurological and functional recovery, using the Modified Rankin Scale. Assessments may be conducted in person or remotely. Safety and outcomes will be reviewed by independent adjudicators. The study duration extends until December 2028, and the primary measurement of success is the degree of disability or dependence in daily activities at 90 days after treatment.
CONDITIONS
Brief Title
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
Research Team
J
Jasmine M Olvany, PhD
A
Alexia Henricks
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
MT + CAS (with IV or oral antiplatelet)
MT + CAT (with oral antiplatelet)
What it is
A method combining mechanical thrombectomy (removal of a blood clot causing stroke) with carotid artery stenting in the setting of tandem or local internal carotid artery occlusion, with either intravenous or oral antiplatelet medication added.
A treatment approach with mechanical thrombectomy followed by carotid angioplasty (widening of the narrowed artery without stenting) and oral antiplatelet medication.
Role in this trial
One of two active intervention arms to determine outcomes of adding carotid stenting with IV or oral antiplatelet therapy after thrombectomy.
Parallel arm evaluating mechanical thrombectomy with angioplasty and oral antiplatelet, without carotid stent placement.
Primary use
Designed for adults with acute ischemic stroke from tandem or proximal internal carotid occlusion, aiming to improve neurological outcomes by restoring blood flow and preventing further clots.
Used for the same stroke population to restore cerebral blood flow without a stent, while reducing new clot formation with antiplatelet therapy.
How it is performed
Participants undergo mechanical thrombectomy to remove the clot, carotid stenting to open the narrowed artery, and receive either intravenous or oral antiplatelet medication during or after the procedure.
Participants receive mechanical thrombectomy followed by balloon angioplasty of the carotid artery, without a stent, plus oral antiplatelet therapy.
Evidence status
Efficacy and comparative safety results are not yet posted for this trial. Existing evidence suggests endovascular therapy is effective for large vessel occlusion stroke, but optimal approach for tandem lesions remains under investigation.
No results from this trial are currently available. Comparative effectiveness of angioplasty versus stenting in this setting is uncertain and remains a subject of clinical study.
Important limitations
As this combination is under investigation, real-world effectiveness and safety remain to be established. Risks can be procedure-related or dependent on antiplatelet regimen but are not yet quantified for this population in this trial.
This approach is also investigational for acute tandem occlusions. The risk-benefit balance and comparative effectiveness are not established, and no outcome data are posted yet.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years - 79Years
All Genders
Eligibility Criteria
You may qualify if you...
Age between 18 and 79 years before the 80th birthday
Symptoms consistent with acute ischemic stroke
Imaging shows anterior circulation occlusion of the internal carotid artery or middle cerebral artery along with proximal carotid occlusion or severe stenosis (≥70%) due to atherosclerosis
National Institutes of Health Stroke Scale (NIHSS) score of 4 or higher
Ability to start endovascular therapy within 16 hours of stroke onset
Pre-stroke modified Rankin Scale (mRS) score between 0 and 2
Signed informed consent obtained
ASPECTS score of 7 or higher on CT or MRI for patients within 6 hours of stroke onset, or specific infarct volume limits for patients treated between >6 to 16 hours
Acute neurological deficit with imaging evidence of tandem lesion (extracranial carotid occlusion 70% to 100%)
Ineligible for intravenous t-PA therapy or failed intravenous t-PA therapy
You will not qualify if you...
Female participants who are pregnant or of childbearing potential with positive pregnancy test
Severe allergy to contrast media not controlled by medications
Persistent high blood pressure (systolic >185 mmHg or diastolic >110 mmHg) despite medication
CT evidence of midline shift, herniation, intracranial hemorrhage, or mass effect with ventricular effacement
Acute bilateral strokes
Contraindications to antiplatelet or thrombolytic therapy, or contrast agents
Intracranial tumors other than small meningioma not requiring surgery for one year
Known bleeding disorders or anticoagulant therapy with high clotting times
Low baseline platelet count (<100,000 per microliter)
Life expectancy less than one year prior to stroke onset
Participation in other randomized clinical trials that could affect study results
Any condition that prevents endovascular procedure or poses significant risk
Proximal carotid stenosis caused by dissection or vasculitis such as Takayasu's Arteritis
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - Up to 16 hours from stroke onset to start treatment
Participants receive mechanical thrombectomy combined with either carotid artery stenting or non-stenting treatments, along with best medical management, based on random assignment. The order of treating intracranial and extracranial lesions is determined by the treating doctor.
Single treatment procedure visit
Follow-up
Duration - 12 months
Participants are assessed for recovery and outcomes at 3 months and 1 year after treatment using neurological and functional scales.
1 to 2 follow-up visits
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Phase II Study of MT200605 for Treating Acute Ischemic Stroke
Randomized, Double-Blind, Placebo-Controlled Trial in Adults 18 to 80 Years
Study to Test Safety and Effectiveness of Super-Bore 87F Aspiration Catheters
for Treating Acute Blockages in Large Brain Arteries
Evaluation of B2065 Cell Injection Safety and Preliminary Effectiveness in Adults with Acute Ischemic Stroke
Randomized, Double-Blind Trial Evaluating Safety and Effects of TAK-755 Compared to Placebo in Adults with Acute Ischemic Stroke
Open-Label Study Evaluating Multiple Doses of LT3001 to Restore Arterial Blood Flow in Adults With Acute Ischemic Stroke
Evaluating Intravenous Tenecteplase Versus Standard Care for Adults With Acute Ischemic Stroke More Than 4.5 Hours After Last Known Well
Multicenter Registry Study of Endovascular Treatment for Acute Ischemic Stroke
Clinical Study of Stroke Recurrence and Characteristics in Patients With Acute Ischemic Stroke and Active Cancer A Multicenter Prospective Observational Study
Treatment of Acute Stroke Caused by Carotid Artery Bifurcation Using Micronet-Covered CGuard Stent with Flow Reversal and Thrombus Removal
Study of Semaglutide Injection for Treating Non-Diabetic Adults With Acute Ischemic Stroke
A National, Phase 2, Randomized Trial Evaluating Safety and Effectiveness
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
PICASSO (Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem Lesion or Local Occlusion) Thrombectomy Randomized Trial: Study Protocol and Rationale.
Sami Al Kasab, Thanh N Nguyen, Mohamad Abdalkader...